CT引导125I粒子治疗非小细胞肺癌的辐射防护护理干预
Radiation protective nursing intervene of 125I seed implantation in non-small cell lung carcinoma guided by CT
-
摘要: 目的 探讨在CT引导下125I粒子植入微创治疗非小细胞肺癌(NSCLC)辐射防护护理干预的措施及注意事项。方法 对89例NSCLC患者实施有计划和验证的125I粒子植入治疗,进行围手术期的全程防护护理干预,观察分析植入治疗的成功率、疗效参数和并发症发生率。结果 科学合理的辐射防护护理干预能保障放射性粒子植入的剂量学分布符合有效和微创的原则,植入治疗成功率达到100%,局部控制有效率为96.7%,1年生存率为92.2%;早期和晚期放射反应发生率分别为14.6%和1.1%。未出现放射性泄漏污染事件。结论 包含全程放疗计划和验证的125I粒子植入疗法,结合科学的辐射防护护理干预措施,对提高NSCLC的疗效和明显降低并发症的发生具有重要的临床价值。Abstract: Objective To research radiation protective nursing intervene and important notice of 125I seeds minimally invasive implantation in non-small cell lung carcinoma(NSCLC)by CT.Methods Under the system of therapy planning system(TPS)and posologic validation, 125I seeds were implanted in 89 cases of NSCLC patients.The consistent radiation protective nursing intervene was used in perioperative period management.The operative successful rate,therapeutic effect and complication rate was observed.Results The scientific radiation protective nursing intervene can ensure that the radioactive dose distribution of 125I seed implantation brachytherapy is consistent with the principles of effective and minimally invasive.The operative successful rate was 100%.The local control rate and 1 year survival rate respectively was 97.4%and 92.2%.But the early and later incidence rate of radioactive damaging effect was 14.6% and 1.1%respectively.Leakage of radioactive contamination has not occurred.Conclusion The consistent TPS and posologic validation 125I seeds implantation integrated scientific radiation protective nursing intervene.It is very important to improve the therapeutic effect of NSCLC and reduce the incidence of complications.
-
[1] 中华医学会.临床技术操作规范放射肿瘤分册.北京:人民军医出版社,2005.117-118.
[2] 陈名,蒋国梁,朱国培.放射肿瘤学临床前瞻性随机试验的设计和实施//蒋国梁.现代肿瘤放射治疗学.上海:上海科技出版社,2003.673.
[3] 中华人民共和国卫生部.GB4792-84放射卫生防护基本标准.1984.
[4] 中华人民共和国卫生部.GB16360-1996临床核医学放射卫生防护标准.北京,1996.
[5] 柴树德.放射性粒子植入治疗支气管肺癌//柴树德,郑广钧.放射性粒子植入治疗胸部肿瘤.天津:天津科学技术出版社,2007:134-208.
[6] Lee W,Daly BD,DiPetrillo TA,et al.Limited resection for non-small cell lung cancer:observed local control with implantation of I-125 brachytherapy seeds.Ann Thorac Surg,2003,75(1):237-242. [7] Turrisi AT.A case against surgery for most Ⅲa non small cell lung cancer.Semin Oncol,2005,32(2 Suppl 3):S6-S8. [8] Siebert FA.Kohr P.Kovács G.Comparison of CT-and radiograph-based post-implant dosimetry for transperineal 125I prostate brachytherapy using single seeds and a commercial treatment-planning software.Strahlenther Onkol,2006,182(2):96-101. [9] 中华医学会.临床诊疗指南-肿瘤分册.北京:中华医学会,2005:128-130.
[10] 冯宁远,谢虎臣,史荣,等.实用放射治疗物理学.北京:北京医科大学、中国协和医科大学联合出版社,1998,33.
.[11] 陆军.125I粒子植入近距离治疗的放射防护.肿瘤学杂志,2004,10(5):363-364.
[12] 姜节卫,夏海英,杜苗.癌症放疗患者抑郁状态与社会支持的相关分析.中华护理杂志,2007,42(11):980-982.
[13] 龚海英,梁建博,刘雨丝.静脉留置针在肿瘤放疗病人输液中的应用及护理.全科护理,2009,7(7):605-606.
[14] 张继勉.放射性粒子组织间永久插植放射治疗的辐射防护研究.中国辐射卫生,2006,15(4):407-411.
计量
- 文章访问数: 1814
- HTML全文浏览量: 196
- PDF下载量: 4